Compare Stocks → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:PDGCNSX:VP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePDGProdigy GoldC$0.00C$0.00▼C$0.00N/AN/AN/AN/AVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceVPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationPDGProdigy GoldN/AN/AN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePDGProdigy GoldN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPDGProdigy GoldN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePDGProdigy GoldN/AN/A0.00N/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPDGProdigy GoldN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipPDGProdigy GoldN/AVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipPDGProdigy GoldN/AVPVodis PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionablePDGProdigy GoldN/AN/AN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableVP, REDD, BWO, and PDG HeadlinesSourceHeadlineCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™tmcnet.com - March 27 at 1:27 PMStates' drug pricing boards off to a slow startmsn.com - March 22 at 8:16 AMGLP-1s set to take drug sales throne from PD-1 inhibitors in 2024mmm-online.com - March 20 at 6:45 PMVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Callmsn.com - February 25 at 2:28 PMAbivax appoints Ana Sharma as Vice President, Global Head of Qualitymarkets.businessinsider.com - February 7 at 8:56 AMMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Healthmarkets.businessinsider.com - January 24 at 1:10 PMSenior Vice Presidentgovtech.com - December 20 at 9:06 AMDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023msn.com - December 14 at 3:30 PMBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsmsn.com - December 7 at 3:45 PMThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsabcnews.go.com - December 7 at 9:38 AMAmneal Pharma in pact with Strides to launch generic Vascepamsn.com - December 1 at 3:25 PMAnavex Life Sciences Appoints Senior VP of Regulatory Affairsmarkets.businessinsider.com - November 6 at 8:21 AMXpeng's vice president suspended amid corruption investigation in supply chain managementfoxnews.com - October 14 at 11:38 PMLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drugmarketwatch.com - October 9 at 6:33 PMStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Integamarkets.businessinsider.com - October 4 at 6:44 AMVice Presidentnewsweek.com - September 19 at 1:02 PMRepublican voters want Donald Trump. And his vice president? How about more Trump?usatoday.com - August 28 at 4:23 AMTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesnews.yahoo.com - August 22 at 4:12 AMVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcriptmsn.com - August 1 at 10:03 PMSee which pharma brands are the strongest and fastest-growing in 2023mmm-online.com - July 12 at 1:54 PMSenior Vice President, Corporate Development and Global Strategywebmd.com - June 9 at 11:51 PMWhat has Kamala Harris done as vice president?news.yahoo.com - May 29 at 8:36 AMAHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricinghealthpayerintelligence.com - April 24 at 7:41 PMMeet our President and Vice Chancellorlse.ac.uk - April 9 at 10:43 PMMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come5 Top-Rated Dividend Stocks With Double-Digit UpsideMarch 25, 2024 11:19 AMView 5 Top-Rated Dividend Stocks With Double-Digit UpsideLow Interest Rates Can Help These Commercial Banks Rally HigherApril 2, 2024 11:38 AMView Low Interest Rates Can Help These Commercial Banks Rally HigherAll Headlines Company DescriptionsProdigy GoldCVE:PDGProdigy Gold Incorporated (Prodigy), is an exploration-stage company. Prodigy is engaged in identifying, acquiring and exploring mineral interests. The Company's projects include Hercules Project, Milestone Project and Magino Mine project. The Hercules Property, consisting of 41 claims, is located approximately 120 kilometers northeast of Thunder Bay. The Company holds 100% interest in the property. The Milestone Project is located approximately 220 kilometers northeast of Thunder Bay. The Milestone Project consists of the Milestone, Klotz Lake and Adel properties. The Milestone property consists of 16 contiguous patented claims in which the Company has an option agreement to earn 100% interest. The Magino Mine project is located 40 kilometres northeast of the town of Wawa, Ontario. Magino is a past producing underground gold mine with production capacity of over 105,000 ounces of gold. In December 2012, the Company divested all its interest to Argonaut Gold Inc.Vodis PharmaceuticalsCNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
